Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
OPRX 
OPTIMIZERx Corp (OPRX)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/22/2025: OPRX (4-star) is a STRONG-BUY. BUY since 6 days. Simulated Profits (-7.70%). Updated daily EoD!
Upturn Star Rating
Above Average Performance
These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.
Number of Analysts
7 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $19.5
1 Year Target Price $19.5
| 4 | Strong Buy |
| 2 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 94.37% | Avg. Invested days 39 | Today’s Advisory Strong Buy |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  4.0 |
| Profits based on simulation | Last Close 10/22/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 349.39M USD | Price to earnings Ratio - | 1Y Target Price 19.5 |
Price to earnings Ratio - | 1Y Target Price 19.5 | ||
Volume (30-day avg) 7 | Beta 1.25 | 52 Weeks Range 3.78 - 20.85 | Updated Date 10/22/2025 |
52 Weeks Range 3.78 - 20.85 | Updated Date 10/22/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.54 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -9.42% | Operating Margin (TTM) 10.92% |
Management Effectiveness
Return on Assets (TTM) 1.33% | Return on Equity (TTM) -8.21% |
Valuation
Trailing PE - | Forward PE 18.94 | Enterprise Value 339134580 | Price to Sales(TTM) 3.34 |
Enterprise Value 339134580 | Price to Sales(TTM) 3.34 | ||
Enterprise Value to Revenue 3.24 | Enterprise Value to EBITDA 326.72 | Shares Outstanding 18565033 | Shares Floating 14282637 |
Shares Outstanding 18565033 | Shares Floating 14282637 | ||
Percent Insiders 15.47 | Percent Institutions 71.59 |
Upturn AI SWOT
OPTIMIZERx Corp
Company Overview
History and Background
OPTIMIZERx Corp, founded in 2006, provides digital health solutions for healthcare providers and patients. They evolved from focusing on sample management to a broader platform for medication access and adherence.
Core Business Areas
- Therapeutic Support: Connects healthcare providers and patients with financial support, such as copay assistance, and other services to improve medication access and adherence.
- Financial Solutions: Offers tools and resources to help patients afford their medications, including savings programs and reimbursement support.
- Patient Engagement: Engages with patients to promote medication adherence, education, and overall health management.
Leadership and Structure
The leadership team includes key executives focused on strategy, finance, technology, and sales. The organizational structure supports the development, marketing, and delivery of their digital health solutions.
Top Products and Market Share
Key Offerings
- OPTIMIZERx Platform: A digital health platform that connects pharmaceutical manufacturers, healthcare providers, and patients to improve medication access and adherence. Market share data is difficult to determine precisely, but the company competes in the growing digital health and patient support services market. Competitors include ConnectiveRx and CoverMyMeds.
- eVoucher Programs: Digital savings programs that enable patients to access discounted medication prices. Market share is part of the overall patient access market, competition with ConnectiveRx and GoodRx. Revenue from eVoucher Programs is significant but difficult to quantify as a standalone figure.
- Therapeutic Support Programs: Programs designed to support patients throughout their treatment journey, including educational resources and adherence tools. Competition with companies offering similar patient support services is present. Revenue is tied to overall platform adoption.
Market Dynamics
Industry Overview
The digital health and patient support services industry is experiencing significant growth, driven by increasing healthcare costs, the growing prevalence of chronic diseases, and the increasing adoption of digital technologies in healthcare.
Positioning
OPTIMIZERx Corp is positioned as a key player in connecting pharmaceutical manufacturers, healthcare providers, and patients to improve medication access and adherence. Competitive advantages include its established platform, extensive network, and focus on ROI for pharmaceutical manufacturers.
Total Addressable Market (TAM)
The TAM for patient support services is estimated to be in the billions of dollars. OPTIMIZERx Corp is positioned to capture a portion of this market by providing digital health solutions that improve medication access and adherence.
Upturn SWOT Analysis
Strengths
- Established platform with a broad network of pharmaceutical manufacturers, healthcare providers, and patients
- Strong focus on delivering ROI for pharmaceutical manufacturers
- Experienced management team with expertise in healthcare and technology
- Proprietary data and analytics capabilities
Weaknesses
- Reliance on pharmaceutical manufacturers for revenue
- Competition from larger, more established players
- Potential for regulatory changes to impact business model
- Relatively small market capitalization
Opportunities
- Expanding into new therapeutic areas and patient populations
- Developing new digital health solutions and services
- Acquiring complementary businesses
- Partnering with healthcare providers and payers
Threats
- Increased competition from established and emerging players
- Changes in healthcare regulations and reimbursement policies
- Economic downturn impacting pharmaceutical spending
- Data security and privacy concerns
Competitors and Market Share
Key Competitors
- CRX
- GDRX
Competitive Landscape
OPTIMIZERx Corp benefits from its comprehensive platform and data capabilities. However, larger competitors have greater resources and brand recognition.
Major Acquisitions
Therapy Brands
- Year: 2022
- Acquisition Price (USD millions): 240
- Strategic Rationale: Expanded OPTIMIZERx's reach into patient support programs and broadened its technology offerings.
Growth Trajectory and Initiatives
Historical Growth: OPTIMIZERx Corp has experienced significant revenue growth over the past few years, driven by increased adoption of its platform and expansion into new markets.
Future Projections: Analysts project continued revenue growth for OPTIMIZERx Corp, driven by increasing demand for digital health solutions and the company's strong competitive position.
Recent Initiatives: Recent initiatives include expanding into new therapeutic areas, developing new digital health solutions, and acquiring complementary businesses.
Summary
OPTIMIZERx Corp is a promising player in the digital health space with a strong focus on medication access and adherence. While it faces competition and relies on pharmaceutical partnerships, its growth trajectory and recent acquisitions are positive signs. Key challenges involve navigating regulatory changes and maintaining data security. The company needs to continually innovate and diversify its revenue streams to ensure long-term success.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Analyst Reports
- Market Research Reports
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Investment decisions should be based on thorough research and consultation with a qualified financial advisor. Market share data is estimated and may not be precise. Financial metrics mentioned are indicative and illustrative.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About OPTIMIZERx Corp
Exchange NASDAQ | Headquaters Waltham, MA, United States | ||
IPO Launch date 1996-10-22 | President & CEO Mr. Stephen L. Silvestro | ||
Sector Healthcare | Industry Health Information Services | Full time employees 128 | Website https://www.optimizerx.com |
Full time employees 128 | Website https://www.optimizerx.com | ||
OptimizeRx Corporation operates as a digital healthcare technology company. The company offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, HUB awareness, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. It also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is based in Waltham, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.